Related Experiment Video
Updated: Mar 17, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
An antibiotic decision-making tool for patients with pneumonia admitted to a medical intensive care unit
Sheng-Feng Huang1, Jung-San Chang2, Chau-Chyun Sheu3
1School of Pharmacy, Master Program of Clinical Pharmacy, College of Pharmacy, Kaohsiung Medical University, Kaohsiung 807, Taiwan; School of Pharmacy, College of Pharmacy, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
Abstract:
Pneumonia is a leading cause of death in medical intensive care units (MICUs). Delayed or inappropriate antibiotic therapy largely increases morbidity and mortality. Multidrug-resistant (MDR) micro-organisms are major reasons for inappropriate antibiotic use. Currently there is no good antibiotic decision-making tool designed for critically ill patients. The objective of this study was to develop a convenient MDR prediction scoring system for patients admitted to MICUs with pneumonia. A retrospective cohort study was conducted using databases and chart reviews of pneumonia patients admitted to a 30-bed MICU from 2012 to 2013. Forward logistic regression was applied to identify independent MDR risk factors for prediction tool development. A total of 283 pneumonia episodes from 263 patients with positive cultures from blood or respiratory secretions were recruited, of which 154 (54.4%) were MDR episodes. Long-term ventilation (OR = 11.09; P = 0.026), residence in a long-term care facility (OR = 2.50; P = 0.005), MDR infection/colonisation during the preceding 90 days (OR = 2.08; P = 0.041), current hospitalisation ≥2 days (OR = 1.98; P = 0.019) and stroke (OR = 1.81; P = 0.035) were identified as independent predictors for MDR pneumonia. The area under the ROC curve of this prediction tool was much higher than that of ATS/IDSA classification (0.69 vs. 0.54; P <0.001). The prediction accuracy of this tool with risk score ≥1 for MDR infections was 63.7%. This simple five-item, one-step scoring tool for critically ill patients admitted to the MICU could help physicians provide timely appropriate empirical antibiotics.
Insights
A new scoring system helps predict multidrug-resistant (MDR) pneumonia in intensive care units. This tool aids clinicians in selecting appropriate antibiotics for critically ill patients, improving outcomes.
Area of Science:
- Critical Care Medicine
- Infectious Diseases
- Clinical Microbiology
Background:
- Pneumonia is a significant cause of mortality in medical intensive care units (MICUs).
- Delayed or incorrect antibiotic treatment increases patient morbidity and mortality.
- Multidrug-resistant (MDR) organisms are a primary driver of inappropriate antibiotic use.
Purpose of the Study:
- To develop a practical scoring system for predicting MDR pneumonia in critically ill patients admitted to MICUs.
- To identify independent risk factors associated with MDR pneumonia in this patient population.
Main Methods:
- A retrospective cohort study analyzed data from 283 pneumonia episodes in MICU patients (2012-2013).
- Forward logistic regression was used to identify independent predictors of MDR pneumonia.
- A novel five-item scoring tool was developed and validated.
Main Results:
- The study identified five independent predictors for MDR pneumonia: long-term ventilation, long-term care facility residence, prior MDR infection/colonization, prolonged hospitalization, and stroke.
- The developed prediction tool demonstrated a higher predictive accuracy (Area Under the ROC Curve = 0.69) compared to ATS/IDSA classification (0.54).
- The tool achieved a 63.7% prediction accuracy for MDR infections with a risk score of ≥1.
Conclusions:
- A simple, five-item scoring system can effectively predict MDR pneumonia in critically ill MICU patients.
- This tool can assist physicians in making timely and appropriate empirical antibiotic decisions.
- Implementation of this scoring system has the potential to improve patient management and outcomes in MICUs.
More Related Videos
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
09:26Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
Related Concept Videos
Pneumonia III: Complications and Assessment
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Acute Pyelonephritis II: Diagnostic Studies and Management
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Urine Studies II: Urine Culture and Sensitivity Test